← Browse by Condition
Medical Condition
cushing disease
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 2
NCT05804669 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Enrollment
18 pts
Location
United States
Sponsor
Crinetics Pharmaceuticals Inc.
NCT00001595
Recruiting
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Enrollment
2,000 pts
Location
United States
Sponsor
Eunice Kennedy Shriver Nationa...
NCT03774446 Phase 2
Recruiting
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Enrollment
13 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center